Purchases and Sales Made in Q4 2021 in Viracta Therapeutics, Inc. (VIRX)
This table provides information about the institutional ownership of Viracta Therapeutics, Inc. (VIRX) during Q4 2021. The information is specifically focused on institutions that hold shares of Viracta Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 02, 2022
Q4 2021
|
Oppenheimer & CO Inc
New York, NY |
SELL
|
- |
-38KClosed |
$128K - $301K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-44.7K- 24.52% |
$151K - $354K
|
138K
$4.13K
|
|
|
Feb 10, 2022
Q4 2021
|
Bailard, Inc.
|
SELL
|
- |
-50KClosed |
$169K - $396K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Blackstone Inc
New York, NY |
SELL
|
- |
-239KClosed |
$804K - $1.89M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-250KClosed |
$841K - $1.98M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-259KClosed |
$871K - $2.05M
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-560K- 97.02% |
$1.89M - $4.43M
|
17.2K
$517
|
|
|
Feb 14, 2022
Q4 2021
|
Adams Street Partners LLC
Chicago, IL |
SELL
|
- |
-730KClosed |
$2.46M - $5.77M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-988K- 92.41% |
$3.33M - $7.81M
|
81.1K
$2.43K
|